Stifel Financial Corp increased its holdings in shares of Healthequity Inc (NASDAQ:HQY) by 456.5% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 216,335 shares of the company’s stock after purchasing an additional 177,462 shares during the quarter. Stifel Financial Corp owned 0.36% of Healthequity worth $10,979,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Healthequity by 105.8% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,544 shares of the company’s stock valued at $127,000 after acquiring an additional 1,308 shares in the last quarter. Riverhead Capital Management LLC grew its position in Healthequity by 75.3% in the 2nd quarter. Riverhead Capital Management LLC now owns 2,629 shares of the company’s stock valued at $131,000 after acquiring an additional 1,129 shares in the last quarter. Oppenheimer Asset Management Inc. grew its position in Healthequity by 7.7% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 2,686 shares of the company’s stock valued at $134,000 after acquiring an additional 191 shares in the last quarter. Fortaleza Asset Management Inc. acquired a new position in Healthequity in the 2nd quarter valued at about $138,000. Finally, D.A. Davidson & CO. grew its position in Healthequity by 15.2% in the 2nd quarter. D.A. Davidson & CO. now owns 3,326 shares of the company’s stock valued at $165,000 after acquiring an additional 439 shares in the last quarter. 98.60% of the stock is owned by hedge funds and other institutional investors.

HQY has been the subject of several research reports. BidaskClub downgraded Healthequity from a “hold” rating to a “sell” rating in a research report on Thursday. Zacks Investment Research downgraded Healthequity from a “buy” rating to a “hold” rating in a research report on Wednesday, November 15th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $56.00 target price on shares of Healthequity in a research report on Tuesday, September 5th. Chardan Capital lifted their target price on Healthequity from $58.00 to $62.00 and gave the company a “buy” rating in a research report on Wednesday, December 6th. Finally, Robert W. Baird reaffirmed a “hold” rating on shares of Healthequity in a research report on Thursday, September 21st. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and eight have given a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $58.33.

In other news, Director Frank Medici sold 316,644 shares of the business’s stock in a transaction dated Monday, October 9th. The stock was sold at an average price of $51.96, for a total transaction of $16,452,822.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Ashley Dreier sold 10,000 shares of the business’s stock in a transaction dated Monday, December 4th. The stock was sold at an average price of $50.97, for a total value of $509,700.00. Following the transaction, the vice president now directly owns 15,652 shares of the company’s stock, valued at $797,782.44. The disclosure for this sale can be found here. Over the last three months, insiders have sold 1,743,212 shares of company stock valued at $91,145,351. Corporate insiders own 29.00% of the company’s stock.

Healthequity Inc (NASDAQ:HQY) opened at $45.72 on Monday. Healthequity Inc has a 52-week low of $37.62 and a 52-week high of $55.31. The company has a market capitalization of $2,773.97, a PE ratio of 65.31, a PEG ratio of 1.99 and a beta of 1.74.

Healthequity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, December 5th. The company reported $0.17 EPS for the quarter, topping the Zacks’ consensus estimate of $0.13 by $0.04. Healthequity had a return on equity of 14.47% and a net margin of 21.08%. The business had revenue of $56.80 million during the quarter, compared to the consensus estimate of $55.27 million. During the same period in the previous year, the company posted $0.10 earnings per share. The business’s revenue for the quarter was up 31.0% on a year-over-year basis. research analysts anticipate that Healthequity Inc will post 0.71 EPS for the current fiscal year.

WARNING: This article was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this article on another domain, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this article can be accessed at https://www.thecerbatgem.com/2017/12/11/healthequity-inc-hqy-position-increased-by-stifel-financial-corp.html.

Healthequity Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthequity Inc (NASDAQ:HQY).

Institutional Ownership by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Stock Ratings for Healthequity Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity Inc and related stocks with our FREE daily email newsletter.